Oregon Health and Science University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Oregon Health and Science University sits in the top decile of US sponsors by registered trial count (#67 of 15,742 sponsors by registered trial count).
Oregon Health and Science University: 546 sponsored US clinical trials, 91 recruiting.
Oregon Health and Science University sponsors 546 registered US clinical trials on ClinicalTrials.gov, 91 of them currently recruiting, and 370 completed. 73 of these trials are in Phase 3-4 (later-stage) and 92 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.
Top-decile sponsor footprint
Oregon Health and Science University ranks in the top decile of sponsors by registered trial count (#67 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
370 of 420 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
546 total, page 6 of 11
Placenta Imaging Project
NCT02749851
The Effectiveness of Alternating Stimulation in Preventing Tolerance in Essential Tremor Patients
NCT02947841
Four Way Crossover Closed Loop With Exercise Detection
NCT02862730
Ambulatory ICU Study for Medically and Socially Complex Patients
NCT03224858
Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)
NCT02824224
Development of an Intrauterine Pressure Threshold to Confirm Tubal Occlusion
NCT04071392
Hypertrophic Cardiomyopathy Pilot Study
NCT02806479
Magnesium Sulfate in Obese Preeclamptics
NCT02835339
Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A Safety and Dose Finding Study
NCT02760056
Measuring Cortisol Levels in Persons With Parkinson's (PD)
NCT02727270
Assessment and Rehabilitation of Central Sensory Impairments for Balance in mTBI
NCT02748109
LARC Forward Contraceptive Counseling at MHCC
NCT02735551
Video Based Mindfulness Based Stress Reduction
NCT02705586
Exercise Detection Study
NCT02688218
Effect of Hypoglycemia on Sleep
NCT02687893
Fatty Acid Oxidation Defects and Insulin Sensitivity
NCT02517307
FEIBA and Use of Blood Products in Cardiac Surgery
NCT02577614
Tecfidera and MRI for Brain Energy in MS
NCT02644083
Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia
NCT02589340
M-gCBT for Women With Provoked Localized Vulvodynia
NCT02919813
Local Effects of Acupuncture and Nerve Conduction Studies
NCT03036657
Impact of Combined Hormonal Contraceptives on UPA
NCT02577601
Whole Body Vibration Training for Healthy Body Composition in Young Adults
NCT02134275
Influence of Myocardial Shortening on Coronary Tortuosity
NCT02741661
Meditation or Health & Wellness Education Via Internet for Adults 50-80 Years Old
NCT02467660
Comparison of Pharyngeal Oxygen Delivery by Different Oxygen Masks
NCT02523586
Regulation of Cervical Mucus Secretion
NCT02969590
Acute Microvascular Changes With LDL Apheresis
NCT02388633
The Effect of a Culturally Sensitive Educational Intervention on Acceptance of Neuraxial Anesthesia
NCT02672397
Use of Sleep Endoscopy to Predict Outcomes of Pediatric Adenotonsillectomy
NCT02693977
Acupuncture for the Prevention of Emergence Delirium in Children Undergoing Myringotomy Tube Placement
NCT02383004
A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youths With Psychosis
NCT02398292
Rouxbe Pilot for MS
NCT02424825
Emergency Contraception and Body Weight: Pilot Study
NCT02408692
Three-way, Cross-over Closed-loop Exercise Study
NCT02241889
Improving Sleep Quality in People With Insomnia
NCT02443649
Prospective Biomarkers of Bone Metabolism in Hemophilia A
NCT02306694
Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants
NCT02249143
Exercise & Brain Health in MS
NCT02263339
Frontal Cortex and Gait Freezing in Parkinson's Disease: Rehabilitation Impact
NCT02236286
Immediate Postplacental IUD Insertion
NCT02169869
Below Knee DVT Study
NCT03805672
Exercise, Brain Imaging, Cognition, and Gait in Parkinsonism
NCT02231073
Circadian Rhythms and Cardiovascular Risk
NCT02202811
Complementary and Alternative Medicine (CAM) for Fibromyalgia
NCT02053090
Effects of Cholinergic Augmentation on Measures of Balance and Gait
NCT02206620
Study to Assess Duration of Indwelling Catheter After Sacrocolpopexy
NCT02189291
Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis
NCT02133664
Pilot Study of Entacapone for Methamphetamine Abuse
NCT02058966
Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study
NCT01908062
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 52 |
| Phase 2 | 40 |
| Phase 3 | 6 |
| Phase 4 | 67 |
Therapeutic Areas
What is open in the Oregon Health and Science University pipeline
91 recruiting of 546 indexed (17% open); 370 completed (68%).
Phase mix: 73 late (III/IV) vs 92 early (I/II) (balanced across stages).
Top condition: Obesity (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Oregon Health and Science University: open-pipeline peers nationwide
Peers matched on 546 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Oregon Health and Science University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 546 trials (± recruiting share)
- Ohio State University · 552 trials · 21% recruiting
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
- Virginia Commonwealth University · 558 trials · 14% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Adagene · 17% recruiting · 6 trials
- Agendia · 17% recruiting · 6 trials
- Akamis Bio · 17% recruiting · 6 trials
- Angiodynamics · 17% recruiting · 12 trials
Related
What to do with this Oregon Health and Science University page
546 registered trials is a research-attention snapshot, not an endorsement of Oregon Health and Science University or any single study.
- 91 of Oregon Health and Science University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Oregon Health and Science University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Oregon Health and Science University pipeline card: 546 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.